Showing results (1681-1690 of 2,022) with videos related to

Sort By:
Pageof 203
Blood Advances|July 2, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphomaClaudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli, et al.
Physical Review Letters|June 12, 2012
High-order-harmonic generation and superradiance in a seeded free-electron laserL Giannessi, M Artioli, M Bellaveglia, et al.
JCO Global Oncology|May 23, 2024
Global Landscape of the Attack of Predatory Journals in OncologyKhalid El Bairi, Dario Trapani, Sara Jamil Nidhamalddin, et al.
La Radiologia Medica|October 6, 2023
Radiomics and artificial intelligence analysis by T2-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging to predict Breast Cancer Histological OutcomeAntonella Petrillo, Roberta Fusco, Maria Luisa Barretta, et al.
Physical Review Letters|July 17, 2015
Two-Color Radiation Generated in a Seeded Free-Electron Laser with Two Electron BeamsA Petralia, M P Anania, M Artioli, et al.
Journal of Medicinal Chemistry|March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1)Ilaria Peretto, Roberto Forlani, Claudia Fossati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical TargetsFlorian Kocher, Alberto Puccini, Gerold Untergasser, et al.
The Oncologist|November 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemicAlessandro Parisi, Riccardo Giampieri, Silvia Villani, et al.
Therapeutic Advances in Medical Oncology|August 28, 2020
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocolAntonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, et al.
ESMO Open|January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II studyC Cardone, A De Stefano, G Rosati, et al.
Pageof 203